| scholarly article | Q13442814 |
| P50 | author | Iris Chaberny | Q42801671 |
| P2093 | author name string | Harald Seifert | |
| Thomas A Wichelhaus | |||
| Frauke Mattner | |||
| Elisabeth Meyer | |||
| Franz-C Bange | |||
| P2860 | cites work | Extended-spectrum beta-lactamases: a clinical update | Q24534999 |
| Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 | ||
| Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period | Q31135323 | ||
| How long do nosocomial pathogens persist on inanimate surfaces? A systematic review | Q33254233 | ||
| Klebsiella pneumoniae with extended spectrum beta-lactamase activity associated with a necrotizing enterocolitis outbreak | Q33330690 | ||
| Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. | Q33690464 | ||
| Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment | Q33722082 | ||
| Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. | Q33973375 | ||
| Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008 | Q34027016 | ||
| The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa | Q34581987 | ||
| Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase | Q34951483 | ||
| Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii | Q35784520 | ||
| Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). | Q36301285 | ||
| Correlation between the genetic diversity of nosocomial pathogens and their survival time in intensive care units. | Q36313868 | ||
| Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases | Q36424079 | ||
| What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? | Q36559365 | ||
| Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil | Q36593879 | ||
| Management of multidrug-resistant organisms in health care settings, 2006. | Q37027940 | ||
| Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis | Q37032817 | ||
| First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital | Q37040812 | ||
| Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
| Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit | Q37401036 | ||
| Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. | Q37418908 | ||
| Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant | Q37718267 | ||
| Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy | Q38474339 | ||
| Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates | Q38475591 | ||
| Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system | Q38561310 | ||
| Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit | Q39816792 | ||
| Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital | Q42640151 | ||
| First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea | Q42653831 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection | Q43108529 | ||
| Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital | Q43154115 | ||
| An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes | Q43204996 | ||
| Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes | Q43232944 | ||
| Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit | Q43628090 | ||
| SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance | Q44297206 | ||
| Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition | Q44309314 | ||
| Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period | Q44485526 | ||
| Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases | Q44943295 | ||
| A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. | Q45923958 | ||
| Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. | Q45956390 | ||
| Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. | Q46123444 | ||
| Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii | Q46242387 | ||
| Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. | Q46329957 | ||
| Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study). | Q46533697 | ||
| Extended spectrum Beta-Lactamase-producing Klebsiella pneumoniae septicaemia outbreak in the Neonatal Intensive Care Unit of a tertiary hospital in Nigeria. | Q46612298 | ||
| The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. | Q46657313 | ||
| An outbreak of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit. | Q46990695 | ||
| Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? | Q50710857 | ||
| How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. | Q51059613 | ||
| Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. | Q54373146 | ||
| Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. | Q54432999 | ||
| First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. | Q54438035 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli isolated in the Al-Amiri Hospital in 2003 and compared with isolates from the Farwania hospital outbreak in 1994-96 in Kuwait. | Q54439037 | ||
| The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study | Q56791640 | ||
| Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection among renal transplant recipients | Q58623683 | ||
| Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts | Q59239387 | ||
| An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase | Q59245522 | ||
| The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum -lactamase-producing strains: a time-series analysis | Q64134022 | ||
| Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections | Q64135161 | ||
| Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital | Q73239627 | ||
| Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting | Q79748694 | ||
| Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit linked to onychomycosis in a healthcare worker | Q80124291 | ||
| Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome | Q80155554 | ||
| Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations | Q80940392 | ||
| Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting | Q81732676 | ||
| Should we screen patients for extended-spectrum beta-lactamase-producing enterobacteriaceae in intensive care units? | Q82890338 | ||
| Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization | Q83614611 | ||
| P433 | issue | 3 | |
| P921 | main subject | hygiene | Q162297 |
| Gram-negative bacteria | Q632006 | ||
| multiple drug resistance | Q643839 | ||
| pathogen spread | Q50156634 | ||
| P304 | page(s) | 39-45 | |
| P577 | publication date | 2012-01-20 | |
| P1433 | published in | Deutsches Ärzteblatt international | Q27722165 |
| P1476 | title | Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology | |
| P478 | volume | 109 |
| Q38152302 | Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices |
| Q38162183 | Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance |
| Q41709726 | Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers |
| Q47631000 | Environmental factors influencing the development and spread of antibiotic resistance |
| Q41662885 | Epidemiology of multidrug-resistant organisms in travellers: Results of a 2-year screening in a German level 1 trauma center |
| Q90400600 | Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks |
| Q35493039 | Identification of nasal colonization with β-lactamase-producing Enterobacteriaceae in patients, health care workers and students in Madagascar |
| Q35817832 | Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study |
| Q41665681 | Management of multiresistant pathogens in urology |
| Q58113851 | Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact |
| Q37694277 | Mortality associated with community-acquired cephalosporin-resistant Escherichia coli in patients admitted to a district hospital in a resource-limited setting. |
| Q36580707 | Susceptibility of multidrug resistant clinical pathogens to a chlorhexidine formulation |
| Q37194890 | The prevalence of nosocomial and community acquired infections in a university hospital: an observational study |
| Q30827546 | The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. |
| Q41660672 | Treatment of gunshot fractures of the lower extremity: Part 1: Incidence, importance, case numbers, pathophysiology, contamination, principles of emergency and first responder treatment |
| Q86957532 | [Chronic wounds and bacteria. Clinical relevance, detection and therapy] |
| Q90295102 | [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options] |
Search more.